Juno Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$324K Hold
1,537
– – 0.11% 62
2026
Q2
$292K Hold
1,537
– – 0.1% 62
2026
Q1
$259K Buy
1,537
+1
+0.1% +$171 0.1% 66
2025
Q4
$259K Hold
1,536
– – 0.1% 61

Other funds holding IBB

Juno Financial Group's IBB Position: Q3 2026 in Review

Juno Financial Group held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 1,537 shares worth $324K. The position accounts for 0.11% of the portfolio, ranked #62.

Juno Financial Group first reported a position in IBB in Q4 2025 and has held it in 4 quarters since. 1,029 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Juno Financial Group held 1,537 shares of iShares Biotechnology ETF worth $324K as of Q3 2026.
  • Juno Financial Group left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.11% of Juno Financial Group's portfolio in Q3 2026, its #62 holding.
  • Juno Financial Group first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 4 quarters since.
  • 1,029 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Juno Financial Group's 13F filing for Q3 2026, filed 27 Oct 2026.